000			01708 a2200481 4500
005			20250516103629.0
264		0	_c20130603
008			201306s 0 0 eng d
022			_a1879-2472
024	7		_a10.1016/j.thromres.2012.07.004 _2doi
040			_aNLM _beng _cNLM
100	1		_aEriksson, Bengt I
245	0	0	_aDabigatran is effective with a favourable safety profile in normal and overweight patients undergoing major orthopaedic surgery: a pooled analysis. _h[electronic resource]
260			_bThrombosis research _cNov 2012
300			_a818-20 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aArthroplasty, Replacement, Hip _xadverse effects
650	0	4	_aArthroplasty, Replacement, Knee _xadverse effects
650	0	4	_aBenzimidazoles _xadverse effects
650	0	4	_aBody Mass Index
650	0	4	_aClinical Trials, Phase III as Topic
650	0	4	_aDabigatran
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aObesity _xblood
650	0	4	_aPostoperative Complications _xprevention & control
650	0	4	_aRisk Factors
650	0	4	_aTreatment Outcome
650	0	4	_aVenous Thromboembolism _xdrug therapy
650	0	4	_abeta-Alanine _xadverse effects
700	1		_aDahl, Ola E
700	1		_aFeuring, Martin
700	1		_aClemens, Andreas
700	1		_aNoack, Herbert
700	1		_aHantel, Stefan
700	1		_aFriedman, Richard J
700	1		_aHuo, Michael
773	0		_tThrombosis research _gvol. 130 _gno. 5 _gp. 818-20
856	4	0	_uhttps://doi.org/10.1016/j.thromres.2012.07.004 _zAvailable from publisher's website
999			_c21981058 _d21981058